Igc Pharma Inc (IGC) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Igc Pharma Inc   (NYSEAMER: IGC)

Select the Financial Report: Select the Period:


Description of Igc Pharma Inc's Business Segments


India Globalization Capital Inc. (IGC) operates primarily in the fields of healthcare, wellness, and technology, focusing on sectors that have significant growth potential. The company has diversified its offerings into various segments, products, and services, working towards serving both local and global markets.

Segments

1. Cannabis and Related Products:
- Medical Cannabis: IGC has been investing in the medical cannabis sector, focusing on developing formulations that can be used for treating various ailments. This includes research and development of cannabinoid-based products that cater to medical needs. The company aims to capitalize on the growing acceptance and legalization of cannabis across various regions.

2. Pharmaceuticals and Nutraceuticals:
- Nutraceutical Products: The company is involved in developing a range of nutraceuticals derived from natural sources, aimed at promoting health and wellness. These products often include dietary supplements and herbal formulations.
- Pharmaceutical Development: IGC is also exploring the pharmaceutical sector by developing drugs that address critical health issues, particularly those related to chronic diseases and conditions prevalent in the markets it targets.

3. Technology Solutions:
- Innovative Technologies: IGC is engaged in developing technology solutions that enhance operations in its core sectors. This could range from software development for healthcare management to digital platforms that facilitate patient interactions or telemedicine.

Products

1. Medicinal Products:
- Cannabidiol (CBD) Forms: The company offers various CBD products aimed at alleviating symptoms of chronic pain, anxiety, and other medical conditions. These products may come in capsules, oils, tinctures, and topical applications.
- Pharmaceutical Formulations: IGC is working on formulations that leverage pharmaceutical compounds combined with natural ingredients to treat illnesses more effectively.

2. Health Supplements:
- Vitamins and Minerals: The company markets a range of health supplements tailored for different demographics and health needs.
- Herbal Products: Formulations based on traditional medicinal practices are also part of the product line, focusing on holistic wellness.

3. Technology Products:
- Software Solutions: The development of software applications that support health care providers in managing patient care, enhancing communication, and streamlining service delivery is a key focus.

Services

1. Consultation Services:
- IGC provides consulting services in relation to product development, regulatory compliance, and market entry strategies in the healthcare sector.

2. Research and Development:
- The company offers R&D services, focusing on creating novel formulations, conducting clinical trials, and ensuring compliance with health regulations.

3. Distribution and Logistics:
- IGC manages logistics and distribution services to ensure that its products reach the market efficiently and effectively. This includes establishing supply chain networks that support the timely delivery of medical and wellness products.

4. Education and Training:
- IGC is likely involved in providing educational resources to healthcare providers, enabling them to understand and utilize its products effectively while also training personnel in the adoption of new technologies.

Conclusion

India Globalization Capital Inc. has positioned itself strategically in the healthcare and wellness sectors, with a focus on innovative products and technology-driven solutions. The company is not only enhancing its product offerings but is also embarking on various services to cater to a comprehensive range of customer needs in health and wellness. By focusing on these segments, IGC aims to be a leading player in the intersection of technology and healthcare, capitalizing on emerging trends and market demands.


Composition of Igc Pharma Inc Revenues by Segments

 
United States U S White Labeling Services    12.08 % of total Revenue
White Labeling Services    207.55 % of total Revenue
Life Sciences Segment    219.62 % of total Revenue

Q2 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
United States U S White Labeling Services 0.03 12.08 %
White Labeling Services 0.55 207.55 %
Life Sciences Segment 0.58 219.62 %
Total 0.27 100 %




Q2 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
United States U S White Labeling Services - -89.12 %
White Labeling Services - 87.07 %
Life Sciences Segment - -
Total - -16.4 %




Q2 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Life Sciences Segment -5.24 -
Total -2.94 -




Q2 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Life Sciences Segment - -
Total - -




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.